Sudo Biosciences
0 followers
Sudo Biosciences is a biopharmaceutical company committed to designing and developing novel, best-in-class medicines to transform patients’ lives. Their lead programs target the tyrosine kinase 2 (TYK2) pseudokinase domain. TYK2 is a key mediator in cytokine signaling pathways that have been linked... Read more
Org chart
Scott Byrd
Chief Executive Officer
Scott Byrd
Collapse
Gordon McMurray
Chief Development Officer
Ian W. Mills
Chief Medical Officer
David Hennings
VP of CMC
Anjali Pandey
Head of Medicinal Chemistry
